Ace the SOCRA CCRP Exam 2026 – Become a Clinical Superstar!

It is important to return or destroy any unused supplies of IP (investigational product) when clinical investigation is terminated, suspended, or completed. Options A, B, and D are incorrect because they do not account for other situations in which the investigation may end before completion, such as a suspension or early termination. By choosing option C, you ensure that no unused IP is left unaccounted for, which could have implications for patient safety and follow-up of study participants. Option A is too frequent and may result in unnecessary waste of IP, while options B and D are not comprehensive enough.